GC Aesthetics® Launches YOUTHLY™: Revolutionizing Breast Implants in China
In a groundbreaking move set to transform the landscape of aesthetic and reconstructive breast solutions in China, GC Aesthetics® has announced the launch of its premium YOUTHLY™ brand.
A New Era for Breast Implants
The YOUTHLY™ portfolio brings to the Chinese market a trio of cutting-edge breast implant innovations:
The Round Collection™ 100% filled: GCA's global best-seller with a proven high patient satisfaction rate backed by 10 years of clinical data.
PERLE™: newly launched in Europe and Latin America— PERLE™ incorporates GCA’s 40+ years of expertise, delivering a distinctive, soft, and natural breast implant. Its safety and effectiveness are backed by results from an initial 3-year study.
Luna XT™: A state-of-the-art option for breast reconstruction, featuring a unique microtextured surface and highly cohesive silicone gel.
These premium silicone breast implants, handcrafted in France and the UK, will be available to women and plastic surgeons across China through an exclusive partnership with G&S Group.
Strategic Expansion in a Growing Market
China represents the world's second-largest market for aesthetic procedures, with projections indicating a 15% annual growth rate. GCA®'s launch of YOUTHLY™ is perfectly timed to meet this growing demand with high-quality, innovative solutions for both augmentation and reconstruction.
Looking to the Future
Carlos Reis Pinto, CEO of GC Aesthetics®, expressed enthusiasm about the launch: "Through the brand, GCA® wants to propose multiple innovative alternatives to Chinese plastic surgeons and patients. My goal is to continue investing and offering premium solutions that are aligned with our commitment to patients and surgeons: 'A Confident Choice for Life™,' covered by a unique lifetime warranty. We’re excited for the future and will soon launch YOUTHLY™ across the Asia-Pacific region.”
For plastic surgeons in China, the arrival of YOUTHLY™ represents an exciting opportunity to offer patients world-class breast implant options backed by years of research, innovation, and clinical success.